Toxicity of Continuous Course Re-irradiation Concurrent With Weekly Cisplatinum and Cetuximab for Recurrent Squamous Cell Carcinoma of the Head and Neck: Report of a Phase 2 Trial

被引:0
|
作者
Nedzi, L. A. [1 ]
Yao, M. [2 ]
Wang, D. [3 ]
Sumer, B. [1 ]
Hughes, R. [1 ]
Lavartu, P. [2 ]
Wong, S. [3 ]
Myers, L. [1 ]
Yordy, J. [1 ]
Truelson, J. [1 ]
机构
[1] UT Southwestern Med Ctr, Dallas, TX USA
[2] Case Western Reserve Med Ctr, Cleveland, OH USA
[3] Med Coll Wisconsin, Milwaukee, WI 53226 USA
关键词
D O I
10.1016/j.ijrobp.2013.06.151
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S58 / S58
页数:1
相关论文
共 50 条
  • [1] Phase 2 Trial of Continuous Course Re-irradiation Concurrent With Weekly Cisplatinum and Cetuximab for Recurrent Squamous Cell Carcinoma of the Head and Neck: Preliminary Report
    Yao, M.
    Wang, D.
    Sumer, B. D.
    Larry, M.
    Truelson, J.
    Randall, H.
    Wong, S.
    Lavertu, P.
    Yordy, J.
    Smith, I.
    Nedzi, L. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S179 - S179
  • [2] Re-irradiation with Cetuximab in relapsed squamous cell carcinoma of the head and neck (HNC)
    Colantonio, I.
    Russi, E.
    Numico, G.
    Cipolat, M.
    Mattiot, V. Polla
    Vitiello, R.
    Merlano, M.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 492 - 493
  • [3] Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck
    Dornoff, Nicolas
    Weiss, Christian
    Roedel, Franz
    Wagenblast, Jens
    Ghanaati, Shahram
    Atefeh, Nateghian
    Roedel, Claus
    Balermpas, Panagiotis
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 (08) : 656 - 664
  • [4] Erratum to: Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck
    Nicolas Dornoff
    Christian Weiß
    Franz Rödel
    Jens Wagenblast
    Shahram Ghanaati
    Atefeh Nateghian
    Claus Rödel
    Panagiotis Balermpas
    [J]. Strahlentherapie und Onkologie, 2015, 191 : 763 - 764
  • [5] RE-IRRADIATION OF RECURRENT AND/OR PERSISTENT SQUAMOUS CELL CARCINOMA OF HEAD AND NECK REGION
    Singh, K.
    Shekhar, S.
    Baruah, J. D.
    Bahadur, A. K.
    Gulati, A.
    Rathi, A. K.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S333 - S333
  • [6] Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck A prospective phase II trial
    Vormittag, L.
    Lemaire, C.
    Radonjic, D.
    Kornek, G.
    Selzer, E.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (03) : 235 - 242
  • [7] Re-irradiation for oligoprogression under Nivolumab in recurrent head and neck squamous cell carcinoma: A case report
    Bonomo, Pierluigi
    Lucidi, Sara
    Desideri, Isacco
    Scotti, Vieri
    Casati, Marta
    Palomba, Annarita
    Ciabatti, Cinzia
    Garlatti, Pietro
    Massi, Daniela
    Gallo, Oreste
    Livi, Lorenzo
    [J]. CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2020, 23 : 16 - 19
  • [8] Dose intense re-irradiation and chemotherapy for recurrent head and neck squamous cell carcinoma
    Salama
    Vokes, EE
    Milano, MT
    Stenson, K
    Witt, M
    Chmura, SJ
    Haraf, DJ
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S490 - S491
  • [9] Outcomes of Phase I Trial of Patients With Recurrent Head and Neck Squamous Cell Carcinoma Treated With Re-Irradiation With Stereotactic Body Radiation Therapy and Concurrent Cisplatin
    Echevarria, M.
    Chung, C.
    Kirtane, K.
    Kish, J. A.
    Muzaffar, J.
    Caudell, J. J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E369 - E369
  • [10] Weekly Cetuximab and Paclitaxel for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Fushimi, Chihiro
    Baba, Daisuke
    Masubuchi, Tatsuo
    Yamazaki, Morio
    Kitani, Yosuke
    Kitajima, Tatsuya
    Tanaka, Junpei
    Hanyu, Kenji
    Tanaka, Naruhisa
    Miura, Kouki
    Tada, Yuichiro
    [J]. IN VIVO, 2020, 34 (05): : 2653 - 2657